The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways an
The world's largest database of cancer mutations can now be used to link mutations with drug treatments in what promises to be a step forward in precision oncology.
The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market.
Immuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic cancer vaccine, but it’s a field that doesn’t stand still.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
